RED BANK, N.J., Jan. 6, 2022 /PRNewswire/ -- Provention Bio, Inc.
(Nasdaq: PRVB), a biopharmaceutical company dedicated to
intercepting and preventing immune-mediated disease, today
announced that management will present at the H.C. Wainwright
BioConnect 2022 Conference, being held virtually January 10-13, 2022.
A replay of the pre-recorded fireside chat will be available
beginning Monday, January 10, at
7:00 am E.T. and can be accessed by
visiting the Events and Webcasts section of the Company's website:
http://investors.proventionbio.com/events. The webcast will be
archived on the Company's website for 30 days following the
presentation. A copy of the presentation will also be posted
on the company's corporate website in the investor's section.
About Provention Bio, Inc.:
Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical
company focused on advancing the development of investigational
therapies that may intercept and prevent debilitating and
life-threatening immune-mediated disease. The Company's pipeline
includes clinical-stage product candidates that have demonstrated
in pre-clinical or clinical studies proof-of-mechanism and/or
proof-of-concept in autoimmune diseases, including type 1 diabetes,
celiac disease and lupus. Visit www.ProventionBio.com for more
information and follow us on Twitter: @ProventionBio.
Internet Posting of Information:
Provention Bio, Inc. uses its
website, www.proventionbio.com, as a means of disclosing
material nonpublic information and for complying with its
disclosure obligations under Regulation F.D. Such disclosures will
be included on the Company's website in the "News" section.
Accordingly, investors should monitor this portion of the Company's
website, in addition to following its press
releases, SEC filings and public conference calls and
webcasts.
Investor Contacts:
Robert Doody, VP of Investor
Relations
rdoody@proventionbio.com
484-639-7235
Sam Martin, Argot Partners
proventionbio@argotpartners.com
212-600-1902
Media Contact:
Lori Rosen, LDR Communications
lori@ldrcommunications.com
917-553-6808
View original content to download
multimedia:https://www.prnewswire.com/news-releases/provention-bio-to-present-at-the-virtual-hc-wainwright-bioconnect-conference-301455154.html
SOURCE Provention Bio, Inc.